the hematocrit bias: a very brief introduction

Posted by Neoteryx on Mar 22, 2018 6:54:00 AM

hematocrit bias blood hematocrit effect.png

For decades, Dried Blood Spot (DBS) cards have served as a useful alternative to painful venipuncutre, cold chain shipping and storage, and other hassles of wet blood collection. However, they have come with their own problems that have sandbagged their widespread adoption.

Chief among the drawbacks of DBS cards is the "hematocrit bias," also known as the "hematocrit effect."

Hematocrit is, in short, the volume percentage of red blood cells in a blood sample. Viscosity determines how well the blood spreads on the filter paper used in DBS. Blood hematocrit generally has an inverse relationship to the spread. Blood with a high hematocrit level results in a smaller dried blood sample, and a lower hematocrit level results in larger-size samples.

The hematocrit bias refers to effect of this relationship on the quality and reliability of data generated from such samples. An unevenly spread sample can easily lead to a disproportionate result. It can be difficult to extract the appropriate amount of the required analyte from the surface of the DBS card. Add to this the variations in paper quality, punching, and other factors, and you've got real problems.

In many cases, it made more sense to just take a larger wet sample, through old methods, to ensure enough blood to hit the "golden standard" for reliable results.

Now, however, there is a better way.


The Mitra® device, driven by Volumetric Absorptive Microsampling (VAMS™) technology, was created in a quest to solve for the limitations of familiar DBS technology in general, and the hematocrit bias in particular. Simply put, microsampling takes the hematocrit bias out of the sampling equation.

With microsampling, a quantitative, volumetrically accurate sample can be easily taken anywhere, at any time, by almost anyone, yielding results comparable to those from wet blood. Microsampling doubles down on the benefits of DBS while overcoming its limitations.

It's no wonder that lab directors who never took DBS seriously before are now buzzing with questions about this new advance. If you're ready to embrace the future of capillary blood sampling without worrying about the hematocrit bias, we've got the answers you seek. Contact Neoteryx now to discover how small samples can do big things for you and your lab.

New call-to-action

Topics: Capillary Blood Sampling